Fabian Ziller
Chemnitz, SN 09117, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma.
Journal: Cancers
Published: January 13, 2026
Enhanced overall and progression-free survival in advanced melanoma patients undergoing targeted therapy alongside antithrombotic treatment - Insights from a multicenter study involving 1296 patients from the prospective skin cancer registry ADOReg.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 12, 2025
Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy - A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 13, 2024
Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events.
Journal: Frontiers in immunology
Published: March 03, 2024
Treatment management for BRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG.
Journal: Journal for immunotherapy of cancer
Published: August 15, 2023
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG.
Journal: Journal for immunotherapy of cancer
Published: February 28, 2023
Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 09, 2022
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis.
Journal: Cancers
Published: June 07, 2021
Clinical determinants of long-term survival in metastatic uveal melanoma.
Journal: Cancer immunology, immunotherapy : CII
Published: June 02, 2021
Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study.
Journal: Cancers
Published: April 17, 2021
Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns-Results of a non-interventional study of the DeCOG.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 15, 2017
Last Updated: 09/26/2026